Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, is licensed in the UK for type 2 diabetes and chronic weight management
Severe DRESS syndrome managed with therapeutic plasma exchange
CM was replaced every 48 h
If needed, dose adjustments or alternative medications may be required
In April 2024, the Federal Trade Commission announced that it was expanding its campaign against pharmaceutical manufacturers improper or inaccurate listing of patents in the Food and Drug Administrations (FDA) Orange Book, disputing junk patent listings for diabetes, weight loss, asthma, and COPD drugs, including Novo Nordisk Inc.s blockbuster weight-loss drug, Ozempic. If the administration revoked Novos extension, patent protection for semaglutide will expire in 2026 as it is scheduled to do in many other countries
A Max Titanium L-Carnitine 2000, em sua apresentao de 60 cpsulas, voltada para quem busca uma dose concentrada de L-Carnitina para potencializar seus treinos e objetivos de emagrecimento